Population Pharmacokinetic and Pharmacodynamic Target Attainment Analysis of Cefazolin in the Serum and Hip Joint Capsule of Patients Undergoing Total Hip Arthroplasty.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
18 03 2021
Historique:
received: 07 10 2020
accepted: 24 01 2021
pubmed: 3 2 2021
medline: 22 6 2021
entrez: 2 2 2021
Statut: epublish

Résumé

The objectives of this study were to evaluate the population pharmacokinetics of prophylactic cefazolin (CFZ) from its serum and hip joint capsule concentrations in patients undergoing total hip arthroplasty and to establish the pharmacodynamic target concentration exceeding the MIC for designing an effective dosing regimen for serum and the hip joint capsule. We analyzed 249 serum samples and 125 hip joint capsule samples from 125 individuals using a nonlinear mixed-effects model. The pharmacodynamic index target value obtained from our results indicates the probability of maintaining CFZ trough and hip joint capsule concentrations exceeding the MIC of 1 mg/liter to account for methicillin-susceptible

Identifiants

pubmed: 33526489
pii: AAC.02114-20
doi: 10.1128/AAC.02114-20
pmc: PMC8097485
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cefazolin IHS69L0Y4T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

Surg Today. 1999;29(12):1233-6
pubmed: 10639702
Comput Methods Programs Biomed. 2005 Sep;79(3):241-57
pubmed: 16023764
J Antimicrob Chemother. 2015 May;70(5):1495-502
pubmed: 25608584
J Bone Joint Surg Am. 1978 Apr;60(3):359-62
pubmed: 649639
AAPS J. 2011 Jun;13(2):143-51
pubmed: 21302010
J Infect Chemother. 2017 Sep;23(9):587-597
pubmed: 28669567
Antimicrob Agents Chemother. 2004 May;48(5):1441-53
pubmed: 15105091
Surg Infect (Larchmt). 2016 Feb;17(1):71-7
pubmed: 26397726
J Infect Dis. 1973 Oct;128:Suppl:S341-6
pubmed: 4744015
Surgery. 1961 Jul;50:161-8
pubmed: 16722001
Am J Health Syst Pharm. 2013 Feb 1;70(3):195-283
pubmed: 23327981
Antimicrob Agents Chemother. 2019 Sep 23;63(10):
pubmed: 31307987
Braz J Cardiovasc Surg. 2017 Jul-Aug;32(4):239-244
pubmed: 28977194
J Pharmacokinet Biopharm. 1978 Apr;6(2):165-75
pubmed: 671222
Ann Thorac Surg. 2006 Jan;81(1):397-404
pubmed: 16368422
Surg Clin North Am. 2009 Apr;89(2):365-89, viii
pubmed: 19281889

Auteurs

Toshiaki Komatsu (T)

Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan t.komatu@kitasato-u.ac.jp.

Yui Natsume (Y)

Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan.

Katsufumi Uchiyama (K)

Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.

Shinsuke Ikeda (S)

Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.

Yoshinori Tomoda (Y)

Laboratory of Clinical Pharmacokinetics, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Tokyo, Japan.

Yoko Takayama (Y)

Department of Infection Control and Infectious Diseases, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kanagawa, Japan.
Department of Infection Control and Prevention, Kitasato University Hospital, Kanagawa, Japan.

Masashi Takaso (M)

Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.

Hideaki Hanaki (H)

Infection Control Research Center, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.

Koichiro Atsuda (K)

Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH